Compensated advanced chronic liver disease (cALD) refers to a spectrum of advanced liver fibrosis and cirrhosis in asymptomatic patients. Elastography, which measure liver stiffness has been recommended as non-invasive diagnostic method.
- What are the limitations when using liver stiffness measurements for diagnosis?
- What role can blood-based serum markers play?
- Should the measurement cut offs be reviewed for different patient populations?
This EASL studio is supported by Boehringer Ingelheim and Siemens Healthineers. EASL has received no input from Boehringer Ingelheim and Siemens Healthineers with regards to the content of this programme.
ℹ️ Please click here to access the podcast version of this EASL Studio episode.